Portfolio spotlight

Portal welcomes Grove Biopharma, an ambitious startup spun out of Northwestern University, as a new venture.

Share

Grove Biopharma is developing a new class of biotherapeutics to address chronic inflammatory and neurodegenerative diseases. Its proprietary Protein-Like Polymers™ (PLPs) are synthetic, cell-penetrant biologics designed to engage well-validated but “undruggable” intracellular targets. By leveraging precision polymer science, protein engineering, and medicinal chemistry, Grove Biopharma aims to unlock new treatment possibilities for diseases with significant unmet medical needs.

 
Visit website